The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial Fibrillation
To access this article, please choose from the options below
The registry was funded by sanofi-aventis, Paris, France; and editorial support was funded by sanofi-aventis.
PII: S0002-9149(09)02487-4
doi:10.1016/j.amjcard.2009.10.012
© 2010 Elsevier Inc. All rights reserved.
